• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

汗孔角化症与皮肤恶性肿瘤。综述。

Porokeratosis and cutaneous malignancy. A review.

作者信息

Sasson M, Krain A D

机构信息

Department of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110, USA.

出版信息

Dermatol Surg. 1996 Apr;22(4):339-42. doi: 10.1111/j.1524-4725.1996.tb00327.x.

DOI:10.1111/j.1524-4725.1996.tb00327.x
PMID:8624658
Abstract

BACKGROUND

Porokeratosis is a disorder of epidermal keratinization manifested clinically by a raised border and histologically by a cornoid lamella. While cutaneous malignancy has been reported to arise in porokeratosis, the risk remains unknown. In the past it has been associated with a history of radiation therapy.

OBJECTIVE

The purpose of this study is to estimate the frequency of cutaneous malignancy arising in porokeratosis and define those patients who are at highest risk.

METHODS

All cases in the English language literature in the last 30 years were reviewed.

RESULTS

Twenty-one (7.5%) of 281 cases reported revealed a malignancy arising within porokeratosis. Large lesions, those of long-standing duration, and the linear type were at greatest risk. Radiation therapy was an infrequently identified risk factor.

CONCLUSION

Porokeratosis is a premalignant condition, with certain groups of patients at greatest risk for malignant transformation.

摘要

背景

汗孔角化症是一种表皮角化异常疾病,临床特征为边界隆起,组织学特征为鸡眼样板层。虽然已有报道称汗孔角化症可发生皮肤恶性肿瘤,但其风险仍不明确。过去,它与放射治疗史有关。

目的

本研究旨在评估汗孔角化症中发生皮肤恶性肿瘤的频率,并确定风险最高的患者群体。

方法

回顾了过去30年英文文献中的所有病例。

结果

281例报告病例中有21例(7.5%)显示在汗孔角化症内发生了恶性肿瘤。大的皮损、病程长的皮损以及线状型皮损风险最高。放射治疗是一个较少见的风险因素。

结论

汗孔角化症是一种癌前病变,某些患者群体发生恶性转化的风险最高。

相似文献

1
Porokeratosis and cutaneous malignancy. A review.汗孔角化症与皮肤恶性肿瘤。综述。
Dermatol Surg. 1996 Apr;22(4):339-42. doi: 10.1111/j.1524-4725.1996.tb00327.x.
2
Cornoid lamellation revisited: apropos of porokeratosis with emphasis on unusual clinicopathological variants.再探鸡眼状层板状结构:关于汗孔角化症,重点关注不寻常的临床病理变异型
Am J Dermatopathol. 2015 Feb;37(2):145-55. doi: 10.1097/DAD.0000000000000039.
3
Fatal squamous cell carcinoma arising from transplant-associated porokeratosis.移植相关汗孔角化症引发的致命性鳞状细胞癌。
J Am Acad Dermatol. 2003 Nov;49(5):931-3. doi: 10.1016/s0190-9622(03)00469-9.
4
Porokeratosis: A Review of Its Pathophysiology, Clinical Manifestations, Diagnosis, and Treatment.掌跖角化病:病理生理学、临床表现、诊断和治疗的综述。
Actas Dermosifiliogr (Engl Ed). 2020 Sep;111(7):545-560. doi: 10.1016/j.ad.2020.03.005. Epub 2020 May 13.
5
Porokeratosis in Singapore: an Asian perspective.新加坡的角化不良症:亚洲视角。
Australas J Dermatol. 2012 May;53(2):e40-4. doi: 10.1111/j.1440-0960.2011.00856.x. Epub 2012 Jan 19.
6
Cancer proneness of linear porokeratosis may be explained by allelic loss.线状汗孔角化症的癌症易感性可能由等位基因缺失来解释。
Dermatology. 1997;195(1):20-5. doi: 10.1159/000245678.
7
Squamous cell carcinoma arising from lesions of porokeratosis palmaris et plantaris disseminata.掌跖播散性汗孔角化症病变引发的鳞状细胞癌。
Eur J Dermatol. 2000 Aug;10(6):478-80.
8
Linear porokeratosis associated with Bardet-Biedl syndrome: A case report.与巴德-比德尔综合征相关的线状汗孔角化症:一例报告。
Pediatr Dermatol. 2019 May;36(3):346-348. doi: 10.1111/pde.13776. Epub 2019 Feb 22.
9
A case of giant porokeratosis with vestiges of a cornoid lamella.1例伴有鸡眼样板残存的巨大汗孔角化症。
J Dermatol. 2005 Nov;32(11):894-8. doi: 10.1111/j.1346-8138.2005.tb00867.x.
10
Pigmented Porokeratosis. A Further Variant?色素性汗孔角化症。另一种变异型?
Am J Dermatopathol. 2016 Mar;38(3):218-21. doi: 10.1097/DAD.0000000000000468.

引用本文的文献

1
First case of penile porokeratosis from Nepal: a case report.尼泊尔首例阴茎汗孔角化症:病例报告。
Ann Med Surg (Lond). 2025 May 20;87(7):4614-4617. doi: 10.1097/MS9.0000000000003403. eCollection 2025 Jul.
2
[Multiple squamous cell carcinomas arising in linear porokeratosis].[线状汗孔角化症中出现的多发性鳞状细胞癌]
Dermatologie (Heidelb). 2025 Aug 19. doi: 10.1007/s00105-025-05565-2.
3
A Patient With Concurrent Hidradenitis Suppurativa and Porokeratosis Palmaris et Plantaris Disseminata: Case Report and Review of Autoinflammatory Keratinization Diseases.
一名同时患有化脓性汗腺炎和播散性掌跖汗孔角化症的患者:病例报告及自身炎症性角化病综述
J Cutan Pathol. 2025 Apr;52(4):272-277. doi: 10.1111/cup.14774. Epub 2025 Jan 3.
4
Disseminated Superficial Actinic Porokeratosis: A Systematic Treatment Review.播散性浅表性光化性汗孔角化症:系统治疗综述
Am J Clin Dermatol. 2025 Jan;26(1):7-21. doi: 10.1007/s40257-024-00903-x. Epub 2024 Nov 1.
5
Malignant Transformation in Porokeratosis Ptychotropica: A Systematic Review.棘层松解性角化不良瘤样恶变:系统回顾。
Acta Derm Venereol. 2024 Oct 10;104:adv40558. doi: 10.2340/actadv.v104.40558.
6
Presentations of Cutaneous Disease in Various Skin Pigmentations: Porokeratosis.不同皮肤色素沉着中皮肤病的表现:汗孔角化症。
HCA Healthc J Med. 2024 Apr 30;5(2):113-123. doi: 10.36518/2689-0216.1682. eCollection 2024.
7
Gene-specific somatic epigenetic mosaicism of FDFT1 underlies a non-hereditary localized form of porokeratosis.FDFT1基因特异性体细胞表观遗传镶嵌现象是局限性汗孔角化症非遗传性局部型的基础。
Am J Hum Genet. 2024 May 2;111(5):896-912. doi: 10.1016/j.ajhg.2024.03.017. Epub 2024 Apr 22.
8
Porokeratoses-A Comprehensive Review on the Genetics and Metabolomics, Imaging Methods and Management of Common Clinical Variants.汗孔角化症——关于常见临床变异型的遗传学、代谢组学、成像方法及管理的综合综述
Metabolites. 2023 Nov 26;13(12):1176. doi: 10.3390/metabo13121176.
9
Bilateral Linear Porokeratosis Treated With Topical Lovastatin 2% Monotherapy.局部应用2%洛伐他汀单一疗法治疗双侧线状汗孔角化症
Cureus. 2023 Aug 17;15(8):e43657. doi: 10.7759/cureus.43657. eCollection 2023 Aug.
10
A Case of Linear Porokeratosis.线状汗孔角化症一例。
Indian Dermatol Online J. 2023 May 25;14(4):552-553. doi: 10.4103/idoj.idoj_408_22. eCollection 2023 Jul-Aug.